Torrent Pharmaceuticals (BOM:500420) Total Liabilities: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:500420 Torrent Pharmaceuticals Ltd BOM:500420
71 GF Score
Price ₹4,952.00
GF Value ₹4,485.13
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Torrent Pharmaceuticals Total Liabilities?

Torrent Pharmaceuticals BOM:500420 -0.26% 71 Total Liabilities is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:500420 with a GF Score™ of 71/100 and a GF Value™ of ₹4,485.13 (Fairly Valued). The stock has 7 warning signs investors should review.

Torrent Pharmaceuticals's Total Liabilities for the quarter that ended in Jun. 2026 was ₹0 Mil.

Torrent Pharmaceuticals's quarterly Total Liabilities increased from Dec. 2025 (₹0.00 Mil) to Mar. 2026 (₹267,271.30 Mil) but then declined from Mar. 2026 (₹267,271.30 Mil) to Jun. 2026 (₹0.00 Mil).

Torrent Pharmaceuticals's annual Total Liabilities declined from Mar. 2024 (₹82,044.30 Mil) to Mar. 2025 (₹73,990.50 Mil) but then increased from Mar. 2025 (₹73,990.50 Mil) to Mar. 2026 (₹267,271.30 Mil).


Torrent Pharmaceuticals Total Liabilities Historical Data

* Premium members only.

The historical data trend for Torrent Pharmaceuticals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Torrent Pharmaceuticals Total Liabilities Chart

Torrent Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 71,468.90 88,137.80 82,044.30 73,990.50 267,271.30

Torrent Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 70,660.00 0.00 267,271.30 0.00
BOM:500420
71GF Score
Torrent Pharmaceuticals Ltd BOM:500420
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Torrent Pharmaceuticals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Torrent Pharmaceuticals's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=83433.3+(118412.4+65425.6
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=267,271

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=443119.6-175848.3
=267,271

Torrent Pharmaceuticals's Total Liabilities for the quarter that ended in Jun. 2026 is calculated as

Total Liabilities=Total Assets (Q: Jun. 2026 )-Total Equity (Q: Jun. 2026 )
=N/A-N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ₹0 Mil mean?
Torrent Pharmaceuticals (BOM:500420) has a Total Liabilities of ₹0 Mil as of Jun. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Torrent Pharmaceuticals and its competitors.
Is Torrent Pharmaceuticals' Total Liabilities too high?
Torrent Pharmaceuticals' current Total Liabilities is ₹0 Mil. Overall, Torrent Pharmaceuticals has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Torrent Pharmaceuticals' Total Liabilities compare to ZTS?
Torrent Pharmaceuticals' Total Liabilities of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Torrent Pharmaceuticals and its competitors. Torrent Pharmaceuticals's current Total Liabilities is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Torrent Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Torrent Pharmaceuticals (BOM:500420) is currently considered Fairly Valued. The stock's GF Value™ is ₹4,485.13, compared to a current price of ₹4,952.00 — trading 10.4% above its estimated fair value. The current Total Liabilities is ₹0 Mil. Torrent Pharmaceuticals' overall GF Score™ is 71/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Torrent Pharmaceuticals (BOM:500420), the current Total Liabilities is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Torrent Pharmaceuticals (BOM:500420) Overvalued in 2026?

Based on GuruFocus' analysis, Torrent Pharmaceuticals stock appears to be overvalued. The current stock price of ₹4,952.00 is trading 10.4% above its estimated GF Value™ of ₹4,485.13. GuruFocus considers Torrent Pharmaceuticals to be Fairly Valued.

Key valuation signals for BOM:500420:

  • Total Liabilities: ₹0 Mil
  • GF Value™: ₹4,485.13 vs. price of ₹4,952.00 (10.4% above fair value)
  • GF Score™: 71/100 with 7 warning signs

No single metric tells the full story. See the BOM:500420 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Torrent Pharmaceuticals Business Description

Other Exchanges TORNTPHARM:India
Address Off Ashram Road, Torrent House, Ahmedabad, GJ, IND, 380009
Torrent Pharmaceuticals Ltd is a drug manufacturing company with a focus on the cardiovascular, central nervous system, Vitamins Minerals Nutrients (VMN), and gastrointestinal therapeutic areas. It operates through the Generic Formulation Business segment. Geographically, the business activities are carried out across Indian and International markets. Maximum revenue for the company is generated from its operations in India.
71GF Score

Get the complete analysis for BOM:500420

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹4,952.00
Price
₹4,485.13
GF Value